FDA
-
-
-
-
-
-
-
Dogwood Therapeutics partners with PRIDCor for antiviral assets deal
-
-
-
-
-
-
-
Dogwood Therapeutics raises $12.5 million in registered direct offering
-
-
-
-
-
-
-
Dogwood Therapeutics Reports Third Quarter 2025 Financial Results
-
-
-
-
-
-
-
Dogwood Therapeutics Announces Enrollment of First Fifty Patients in Ongoing Halneuron® Phase 2b Trial
-
-
-
-
-
-
-
Dogwood Therapeutics, Inc. Receives Nasdaq Confirmation of Compliance
-
-
-
-
-
-
-
Dogwood Therapeutics, Inc. Announces Pricing of $4.8 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
-
-
-
-
-
-
-
Virios Therapeutics (VIRI) to merge with Wex Pharmaceuticals, form Dogwood Therapeutics (DWTX)
-
325,256 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

